In mouse models of traumatic brain injury (TBI), SAA levels can be elevated in both blood and liver early on, and serum SAA may serve as a new, neuroinflammation-based biomarker for acute TBI, with its levels correlating to the severity of the injury (Wicker et al., 2019). Here, SAA2 is linked to brain injury.